Ligand Pharmaceuticals Inc (LGND)
Income Tax Expense
$40.74M
TTM · Period ending: · USD
LGND Income Tax Expense
Latest reported$40.74Mperiod ending
Latest reported$40.74Mperiod ending
LGND TTM Income Tax ($4.90M → $40.74M)
TTM income tax expense
High-resolution chart · PNG
LGND income tax expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Income Tax Expense (USD) |
|---|---|
| 40,742,000 | |
| 31,322,000 | |
| 34,507,000 | |
| 14,399,000 | |
| -8,632,000 | |
| -28,487,000 | |
| 6,550,000 | |
| 13,571,000 | |
| 10,867,000 | |
| 25,227,000 | |
| 9,841,000 | |
| 56,205,000 | |
| 60,785,000 | |
| 55,966,000 | |
| 47,829,000 | |
| 946,000 | |
| -227,000 | |
| 6,287,000 | |
| -9,840,000 | |
| -10,621,000 | |
| -17,068,000 | |
| -13,611,000 | |
| -7,553,000 | |
| -5,972,000 | |
| -5,681,000 | |
| -15,323,000 | |
| 167,337,000 | |
| 153,840,000 | |
| 170,324,000 | |
| 196,352,000 | |
| 30,009,000 | |
| 81,991,000 | |
| 73,772,000 | |
| 53,595,000 | |
| 44,676,000 | |
| 17,356,000 | |
| 13,871,000 | |
| 7,748,000 | |
| 10,328,000 | |
| -542,000 | |
| -217,957,000 | |
| -213,811,000 | |
| -217,490,000 | |
| -216,696,000 | |
| 683,000 | |
| 371,000 | |
| 409,000 | |
| 269,000 | |
| 205,000 | |
| 362,000 | |
| 375,000 | |
| -1,400,000 | |
| -1,318,000 | |
| -1,090,000 | |
| -1,191,000 | |
| 940,000 | |
| 820,000 | |
| 623,000 | |
| -13,120,000 | |
| -17,550,000 | |
| -17,153,000 | |
| -16,669,000 | |
| -2,617,000 | |
| -217,000 | |
| -636,000 | |
| -1,261,000 | |
| -1,535,000 | |
| -234,000 | |
| 2,756,000 | |
| 1,726,000 | |
| -55,000 | |
| -2,739,000 | |
| -8,089,000 | |
| -11,284,000 | |
| -18,697,000 | |
| -51,903,000 | |
| -50,371,000 | |
| -46,128,000 | |
| -36,917,000 | |
| -788,000 | |
| 57,000 | |
| 56,000 | |
| 59,000 | |
| -2,000 | |
| 2,885,000 | |
| 5,819,000 | |
| 8,672,000 | |
| -34,676,000 | |
| -37,580,000 | |
| -40,531,000 | |
| -43,404,000 | |
| -25,868,000 | |
| -25,868,000 | |
| -23,097,000 | |
| -18,869,000 | |
| 17,507,000 | |
| 20,692,000 | |
| 20,871,000 | |
| 19,858,000 | |
| 25,739,000 |